Lactate and pyruvate stimulate the conversion of glucose to glycogen in hepatocytes by y a mechanism that does not involve gluconeogenic flux  by Tosh, David & Agius, Loranne
ELSEVIER Biochimica et Biophysica Acta 1268 (1995) 165 - 170 
Biochi~ic~a et Biophysica A~ta 
Lactate and pyruvate stimulate the conversion of glucose to glycogen in 
hepatocytes by a mechanism that does not involve gluconeogenic flux 
David Tosh 1, Loranne Agius * 
Department of ~edicine, The Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, NE2 4HH, UK 
Received 2January 1995; revised 4 April 1995; accepted 20 April 1995 
Abstract 
Glycogen synthesis in hepatocytes was determined at various concentrations of CO 2 and medium HCO 3 to modulate cell pH. 
Glycogen synthesis from glucose was highest in acidic conditions (5% CO2/12.5 mM HCO 3) and lowest in alkaline conditions (2.5% 
CO2/25 mM HCO~-). Physiological concentrations of lactate/pyruvate (2 mM/0.2 mM) stimulated the conversion of glucose to 
glycogen in all media examined and mercaptopicolinate, n inhibitor of gluconeogenesis, caused a similar stimulation as lactate/pyru- 
vate. In alkaline media, the s~Eimulation bymercaptopicolinate ndby lactate/pyruvate was additive, indicating that the latter is not due to 
gluconeogenic flux. In acidic media, the stimulation by both lactate/pyruvate nd mercaptopicolinate was inhibited by amiloride, an 
inhibitor of Na+/H + exchange. Since Na+/H ÷ exchange is activated when cell pH falls below a certain threshold, it is postulated that 
lactate and pyruvate stimulate the conversion of glucose to glycogen through cellular acidification. 
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1. Introduction 
Studies on glycogen synthesis in the perfused liver and 
freshly isolated hepatocyte suspensions did not appear to 
support he classic view that glucose is the major precursor 
of hepatic glycogen and led to a hypothesis that gluco- 
neogenic flux plays an important role in hepatic glycogen 
synthesis and that glucose is a poor substrate for hepatic 
glycogen [1]. This hypothesis, known as the glucose para- 
dox, was based on the failure of freshly isolated hepatocyte 
suspensions to synthesize glycogen from physiological 
[glucose] and the observation that maximum rates of glyco- 
gen synthesis in vitro are attained in the combined pres- 
ence of glucose and gluconeogenic precursors [1-3]. Sev- 
eral gluconeogenic precursors, including fructose, dihy- 
droxyacetone, amino acids and lactate and pyruvate were 
found to stimulate glycogen synthesis and to potentiate the 
activation of glycogen synthase by glucose [4]. It was 
thereby assumed that gluconeogenic flux plays an impor- 
tant role in hepatic glycogen accumulation. The relative 
contributions of glucose and gluconeogenic precursors to 
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hepatocyte glycogen synthesis have generally been deter- 
mined only at unphysiologically high concentrations of
gluconeogenic precursors [5] and whether physiological 
concentrations of these substrates are important contribu- 
tors to hepatic glycogen is not established. 
Studies in vivo, which were designed to estimate the 
extent by which hepatic glycogen is synthesized from 
glucose by a direct pathway (glucose ~ glucose-6-P 
UDP-glucose ~ glycogen), as opposed to an indirect path- 
way where glucose is first converted to gluconeogenic 
precursors which are subsequently converted to glucose, 
generally did not distinguish between conversion of glu- 
cose to gluconeogenic precursors in extrahepatic tissues 
and uptake of these precursors by the liver as compared 
with intrahepatic glucose cycling between glycolysis and 
gluconeogenesis. It is frequently assumed that evidence for 
the indirect pathway as determined in vivo [2,3] represents 
uptake of gluconeogenic precursors by the liver [6]. How- 
ever, studies of glucose metabolism by isolated liver cells 
have established that a high and variable proportion of 
glucose cycles between glycolysis and gluconeogenesis 
[7-10]. Thus flux through the indirect pathway as deter- 
mined in vivo may represent hepatic uptake of glucose and 
substrate cycling between glycolysis and gluconeogenesis 
rather than hepatic uptake of gluconeogenic precursors. 
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Although several gluconeogenic precursors are known to 
stimulate the conversion of glucose to glycogen in hepato- 
cytes in vitro, the action of at least some of these sub- 
strates is now known not to involve gluconeogenic flux. 
The stimulation of glycogen synthesis by amino acids is 
not inhibited by mercaptopicolinate n inhibitor of gluco- 
neogenesis [11] and has been attributed to amino acid-in- 
duced cell swelling [12]. The stimulation of glycogen 
synthesis by fructose and sorbitol correlates with transloca- 
tion of glucokinase [13,14] and may be explained by 
activation of glucokinase through dissociation from its 
regulatory protein [15]. Physiological concentrations of 
lactate and pyruvate stimulate glycogen synthesis in hepa- 
tocytes and the increase can be largely accounted for by 
stimulation of glucose conversion to glycogen [10]. 
Whether this effect is due to gluconeogenic metabolism of 
lactate and pyruvate is not established. Glycogen synthesis 
in hepatocytes i  stimulated not only by amino acid-in- 
duced swelling and by hypoosmotic swelling [12] but also 
by ionic conditions which induce cell acidification, for 
example an increase in [CO 2 ] or replacement of NaC1 by 
Na-acetate [16,17]. The secondary ionic mechanisms trig- 
gered by cell acidification are postulated to be involved in 
the stimulation of glycogen synthesis [16-18]. 
We report in this study that the stimulation of glycogen 
synthesis by physiological concentrations of lactate and 
pyruvate, like the stimulation by amino acids, is not inhib- 
ited by mercaptopicolinate, indicating that it is not medi- 
ated by their gluconeogenic metabolism. We postulate that 
lactate and pyruvate stimulate glycogen synthesis through 
an analogous mechanism as acetate-induced cell acidifica- 
tion and cell swelling through the compensatory ionic 
mechanisms that regulate cell pH. 
2. Materials and methods 
[U-14C]glucose and with other additions as indicated. The 
medium contained either 12.5 mM or 25 mM HCO 3 and 
was equilibrated with either 2.5% or 5% CO 2. These 
concentrations of CO 2 and HCO 3 were selected in order 
to modulate intracellular pH, as described previously [19]. 
Increasing the [CO 2 ] at constant [HCO 3 ] decreases intra- 
cellular pH [19]. For experiments with a Na+-free medium, 
the composition was as in [16]. On termination of the 
incubations the hepatocyte monolayers were extracted in 
0.1 M NaOH [9]. The incorporation of ~4C-label into 
glycogen was determined after ethanol precipitation of the 
glycogen [9]. Cell glycogen was determined enzymically 
by hydrolysis with amyloglucosidase [9]. Cell protein was 
determined by a Lowry method [20]. Glucose conversion 
to glycogen was determined from the incorporation of 
~4C-label into glycogen and is expressed as nmol of glu- 
cose incorporated/3 h per mg of cell protein. Glycogen 
deposition represents he increment in glycogen during the 
3 h incubation and is expressed as nmol of glucosyl units 
deposited as glycogen/3 h per mg protein. Results are 
expressed as means + S.E.M. for the numbers of cultures 
indicated. Statistical analysis was by Student's t-test. 
3. Results 
3.1. Effects of lactate/pyruvate and mercaptopicolinate 
Rates of glycogen deposition and of incorporation of 
[ 14 C]glucose into glycogen were determined in media con- 
taining either 12.5 mM or 25 mM HCO 3 and equilibrated 
with either 2.5% or 5% [CO 2] (Table 1) to modulate 
intracellular pH [19]. In control incubations, without mer- 
captopicolinate or lactate/pyruvate, glycogen deposition 
and glucose conversion to glycogen were highest in the 
2.1. Materials 
Sources of materials were as described previously [9,10]. 
2.2. Hepatocyte isolation and culture 
Hepatocytes were isolated by collagenase perfusion of 
the liver of male Wistar rats (body wt. 220-280 g) fed ad 
libitum [9]. The were cultured in monolayer in Minimum 
Essential Medium (MEM) containing 20 mM Hepes and 
5% (vol/vol) newborn calf serum. After cell attachment (4
h), the medium was replaced by serum-free MEM contain- 
ing 10 nM dexamethasone and the monolayers were cul- 
tured for 16 h [9]. 
2.3. Glycogen deposition and glucose conversion to glyco- 
gen 
After the 16 h preculture the hepatocyte monolayers 
were incubated for 3 h in fresh MEM containing 10 mM 
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Fig. 1. Effects of [mercaptopicolinate] on glycogen synthesis from glu- 
cose. Hepatocyte monolayers were incubated for 3 h in MEM containing 
10 mM[U-14C]glucose and the [mercaptopicolinate] indicated. The 
medium contained either 12.5 mM (O) or 25 mM (0)  NaHCO~- and 
was equilibrated with 5% CO 2. Glycogen synthesis was determined from 
the incorporation of [J4C]glucogen into glycogen and is expressed as 
nmol of glucose incorporated/3 h per mg of protein. 
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Table 2 
Effects of amiloride on glucose conversion toglycogen i  hepatocytes 
Additions: [CO 2 ]/[HCO 3 ] (pH) Amiloride MP Glucose conversion toglycogen (nmol of[ 14C]glucose/3 h per mg) 
None Lac/pyr Insulin 
5%/12.5 mM (7.2) 
5%/25 mM (7.4) 
2.5%/12.5 mM (7.4) 
2.5%/25 mM (7.6) 
- - 31+ l 46+3 72+6 
- + 57+ 11 54_+5 78+6 
+ - 30+ 1 39+4a 56-t-8 a 
+ + 40+3 a 27+ 1 aa 63+6 a 
- - 19+1 42+4 58+7 
- + 42+2 52+3 79+8 
+ - 32+5 ~a 57+9 a 47+ 3 a 
+ + 49+2 53-t-8 74+7 
- - 18+3 35___5 68+ l0 
- + 44+7 70+9 108+ 18 
+ - 39_+4 ~ 59_+4 aa 74_+ 10 
+ + 65+9 a 68-+8 92-+ 16 
- - 14_+2 21_+3 46+ 10 
- + 26+5 41 +6 68___ 13 
+ - 35 -+5 a, 45+7 a~ 52_+ 10 
+ + 49 5-7 a~ 66+9aa 80+ 17 
Hepatocyte monolayers were incubated as in Table 1 without or with 1 mM amiloride, 0.5 mM mercaptopicolinate (MP), lactate/pyruvate (2.0 mM/0.2 
raM) or insulin (10 nM) as indicated. Values are means -i- S.E.M. for 4 experiments. 
a P(0.05; aa P(0.005 amiloride vs respective control. 
acidic medium (5% CO2/12.5 mM HCO 3, pH 7.2) and 
lowest in the alkaline medium (2.5% CO2/25 mM HCO 3, 
pH 7.6) as shown previously [17]. Mercaptopicolinate (0.5 
mM) and lactate/pyruvate (2.0/0.2 raM) caused a similar 
stimulation of glycogen deposition and of [14C]glucose 
incorporation i to glycogen (P  < 0.01) in the various me- 
dia. This stimulation was lower than that caused by in- 
sulin. In the alkaline medium the stimulation by mercap- 
topicolinate and lactate/pyruvate was additive. In the neu- 
tral media, the combined stimulation was greater (P  < 
0.05) than with mercaptopicolinate lone and in the acidic 
medium the combined effects of mercaptopicolinate and 
lactate/pyruvate w re not additive. 
Because the effects of mercaptopicol inate and 
lactate/pyruvate were not additive in the acidic medium, 
we determined the effects of varying [mercaptopicolinate] 
at 12.5 mM and 25 mM HCO 3 to evaluate whether the 
mercaptopicolinate effect is pH-dependent (Fig. 1). The 
stimulation of glycogen synthesis by mercaptopicolinate is 
biphasic with maximum stimulation at 0.5-1.0 mM and a 
smaller stimulation or net inhibition at higher concentra- 
tions. This inhibition was greater in the more acidic 
medium, which may explain the lack of additive stimula- 
tion by mercaptopicolinate and lactate/pyruvate in the 
acidic medium. 
3.2. Effects of  amiloride 
Replacement of NaC1 by either Na-acetate or K-acetate 
causes intracellular acidification and secondary cell 
swelling [21] and stimulation of glycogen synthesis [17]. 
Amiloride, an inhibitor of Na+/H ÷ exchange, inhibits 
both the swelling and the stimulation of glycogen synthesis 
caused by Na-acetate [17]. We used amiloride to determine 
whether the stimulation of glycogen synthesis by 
lactate/pyruvate or mercaptopicolinate may involve acti- 
vation of Na+/H + exchange (Table 2). In the acidic 
medium, amiloride did not affect the basal rate of glycogen 
synthesis, but it suppressed the stimulation by mercaptopi- 
colinate, lactate/pyruvate and insulin. In the neutral me- 
dia, amiloride stimulated the basal rate (P  < 0.05) but had 
little effect on the stimulated rates, and in the alkaline 
medium amiloride increased both the basal and stimulated 
rates of glycogen synthesis. Mercaptopicolinate and lac- 
tate/pyruvate also stimulated glycogen synthesis (P  < 
0.05) in a Na+-free medium (control, 16 ___ 2, mercaptopi- 
colinte, 54 _+ 2; lactate/pyruvate, 33 _+ 4, nmol /3  h per 
mg, means _+ S.E.M., n = 3). Amiloride increased the basal 
rate of glycogen synthesis in the Na+-free medium (P  < 
0.05) but did not counteract the stimulation by mercaptopi- 
colinate or lactate/pyruvate (amiloride, 28 _+ 3; amiloride 
+ mercaptop ico l inate ,  51 _+ 2; ami lo r ide  + 
lactate/pyruvate, 41 + 7), indicating that the stimulation 
by amiloride is independent of Na+/H + exchange. 
4.  D iscuss ion  
Mercaptopicolinate is an inhibitor of phosphoenolpyru- 
vate carboxykinase [22] and thereby inhibits the conver- 
sion of lactate and pyruvate to glucose-6-P [9,10]. At 
concentrations of 0.5 mM it causes more than 80% inhibi- 
tion of gluconeogenesis from pyruvate [9]. The failure of 
mercaptopicolinate to counteract the stimulation of glyco- 
gen synthesis by amino acids was the first evidence that 
this effect by amino acids is not mediated by their gluco- 
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neogenic metabolism [11]. Later work established that the 
mechanism of action of anfino acids is due to cell swelling 
[12,24]. This study shows that mercaptopicolinate does not 
counteract stimulation of glycogen synthesis by 
lactate/pyruvate in incubations in neutral and alkaline 
conditions and establishes that the stimulatory effects of 
lactate/pyruvate are not mediated via gluconeogenic flux. 
The stimulation of glycogen synthesis by mercaptopi- 
colinate in basal conditions has been demonstrated previ- 
ously in both hepatocyte suspensions [11,12] and cultures 
from adult [9,10] and fetal rats [23]. This effect of mercap- 
topicolinate has been attributed to cell swelling [12]. The 
present study shows that amiloride, an inhibitor of 
Na+/H + exchange, counteracts he stimulation of glyco- 
gen synthesis by both mercaptopicolinate and 
lactate/pyruvate during incubation in acidic conditions. 
This is similar to the stimulation of glycogen synthesis by 
Na-acetate [17], which causes cellular acidification as a 
result of uptake of the free acid and cell swelling because 
of secondary activation of Na+/H + exchange [21]. The 
suppression by amiloride of the stimulation of glycogen 
synthesis by insulin can also be explained by insulin-in- 
duced activation of Na+/H + exchange and consequent 
cell swelling [16-18,24]. The Na ÷/H ÷ exchanger in hepa- 
tocytes operates only when cytoplasmic pH is below the 
physiological range [25]. In neutral conditions Na÷-HCO3 
cotransport is the main re~gulator f cell pH [25]. This may 
explain why inhibitory effects of amiloride are only ob- 
served in the acidic medium. The mechanism by which 
amiloride stimulates glycogen synthesis in neutral and 
alkaline conditions is not known. This stimulation is also 
observed in the Na÷-free medium. 
We postulate that the stimulation of glycogen synthesis 
by lactate/pyruvate shares a similar mechanism as the 
stimulation by acetate or [CO 2] and involves intracellular 
acidification and swelling [20] by ionic mechanisms in- 
volving activation of Na÷/H + exchange in acidic condi- 
tions and of other ion tran,;porters and possibly Na+-HCO3 
cotransport in alkaline or neutral conditions. This hypothe- 
sis is based on the following observations: first, the stimu- 
lation of glycogen synthesis by lactate/pyruvate and mer- 
captopicolinate was additive in neutral and alkaline condi- 
tions but not in acidic conditions (5% CO2/12.5 HCO3), 
suggesting that it shares a common mechanism as CO2-in- 
duced acidification; secondly, the stimulation by both lac- 
tate/pyruvate and by mercaptopicolinae in the acidic 
medium was suppressed by amiloride; thirdly, the stimula- 
tion by lactate/pyruvate and mercaptopicolinate was also 
observed in a Na÷-free medium, suggesting that uptake 
probably occurs independent of Na ÷. At physiological 
concentrations, lactate anti pyruvate are taken up by hepa- 
tocytes by a transporter-mediated process rather than by 
free diffusion of the free acid [26-28]. The kinetic charac- 
teristics of the hepatocyte lactate transporter suggest that it 
may be similar to the erythrocyte anion transporter [28] 
which is able to transport several monocarboxylate anions 
and is pH-dependent [29]. This transporter may involve 
either H ÷ symport or OH- antiport and both these mecha- 
nisms would result in cellular acidification during cellular 
accumulation of lactate anion [29]. 
We infer from these findings that at physiological con- 
centrations of lactate/pyruvate, gluconeogenic flux does 
not have an important role in glycogen synthesis n hepato- 
cytes from fed rats. We have shown that hepatocytes 
derived from different nutritional states (fed, 24 h fasted 
and 24 h fasted/3 h refed) differ not only in their overall 
rates of glycogen synthesis from glucose but also in the 
extent by which glucose cycles between glycolysis and 
gluconeogenesis, and in the extent by which 6-tritium of 
glucose is lost by mechanisms that do not involve cycling 
between glycolysis and gluconeogenesis [9,10]. Both these 
mechanisms would contribute to some of the estimates of 
the indirect pathway of glycogen synthesis as determined 
in vivo [2,3]. It is likely that gluconeogenic flux may be 
quantitatively more important in cells from diabetic rats 
which have a low activity of glucokinase and higher 
activities of gluconeogenic enzymes [30] and possibly also 
after refeeding 48-h fasted rats. These situations, however, 
are not representative of glycogen synthesis in the normal 
diurnal cycle. We conclude from previous tudies [9,10,31] 
and the present data that in hepatocytes from normal 
(nondiabetic) rats glucose is the predominant substrate for 
hepatic glycogen synthesis and that stimulation of glucose 
conversion to glycogen by physiological concentrations of 
lactate/pyruvate is not mediated by gluconeogenic flux. 
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